sodium thiosulfate has been researched along with Cancer of Larynx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mihoki, T; Nakashima, T; Ono, T; Tanaka, N; Umeno, H | 1 |
| Ferguson, R; Flick, P; Fontanesi, J; Howell, SB; Kerber, C; Kumar, P; Los, G; Murry, T; Orloff, L; Palmer, R; Pellitteri, P; Robbins, KT; Seagren, S; Thomas, JR; Vicario, D; Weir, A; Weisman, R; Wong, FS | 1 |
2 other study(ies) available for sodium thiosulfate and Cancer of Larynx
| Article | Year |
|---|---|
Selective (intra-arterial), rapid infusion chemo-radiotherapy to preserve the larynx in advanced laryngeal carcinoma: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Antidotes; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Thiosulfates; Thyroid Gland; Treatment Outcome; Voice Quality | 2009 |
A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidotes; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage; Survival Rate; Thiosulfates | 1996 |